Venlafaxine Hydrochloride
Product Images NDC 63187-224

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 63187-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (150 mg Bottle Label)

Principal Display Panel (150 mg Bottle Label)
Chemical structure diagram of Venlafaxine Hydrochloride, showing its molecular framework and bond arrangement as depicted in the image.*
FDA Label Image

Principal Display Panel (150 mg Bottle Label)

Principal Display Panel (150 mg Bottle Label)
Chemical structure of Venlafaxine Hydrochloride, showing the molecular configuration of the active ingredient.*
FDA Label Image

Principal Display Panel (150 mg Bottle Label)

Principal Display Panel (150 mg Bottle Label)
Chemical structure of Venlafaxine Hydrochloride, depicted as a line and letter diagram showing atoms and bonds characteristic of the molecule.*
FDA Label Image

Embossed Image (Image 04)

Embossed Image (Image 04)
Chemical structure of Venlafaxine Hydrochloride, showing the molecular arrangement with rings and functional groups represented by lines and bonds.*
FDA Label Image

Embossed Image (Image 05)

Embossed Image (Image 05)
Chemical structure of venlafaxine hydrochloride, showing the molecular arrangement of atoms and bonds characteristic to this active ingredient.*
FDA Label Image

Figure 1 (Venlafaxine 02)

Figure 1 (Venlafaxine 02)
A chart titled 'Interacting Drug' showing the pharmacokinetic fold change and 90% confidence intervals for analytes venlafaxine and desvenlafaxine (ODV) in the presence of various interacting drugs such as ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The horizontal axis represents the change relative to the reference value, with plotted points showing the effect on Cmax and AUC. Recommendations for each interacting drug are provided in the right column, including dose adjustments or cautions.*
FDA Label Image

Figure 2 (Venlafaxine 03)

Figure 2 (Venlafaxine 03)
A figure titled 'Interacting Drug' showing a comparison of PK fold change and 90% confidence intervals for various analytes including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis represents change relative to the reference value, with markers indicating whether dose adjustment or caution is recommended.*
FDA Label Image

Figure 3 (Venlafaxine 04)

Figure 3 (Venlafaxine 04)
A chart displaying pharmacokinetic changes in venlafaxine and its metabolite ODV across special populations, including various degrees of hepatic and renal impairment, CYP2D6 polymorphism, age over 60, and gender. The graph shows fold changes with 90% confidence intervals and dosage recommendations based on these changes relative to reference values.*
FDA Label Image

Chemical Structure (Venlafaxine 05)

Chemical Structure (Venlafaxine 05)
Chemical structure of venlafaxine hydrochloride, showing its molecular framework with key functional groups labeled, including a cyclohexanol ring, aromatic ring, and dimethylaminoethyl side chain.*
FDA Label Image

63187-224-30 (Venlafaxine 06)

63187-224-30 (Venlafaxine 06)
Venlafaxine HCl 37.5 mg ER Capsules, package of 30, from labeler Proficient Rx LP. The label states each capsule contains Venlafaxine Hydrochloride equivalent to 37.5 mg of Venlafaxine. Storage instructions specify 20°-25°C and a caution to keep the medication out of reach of children. The label also includes manufacturing lot and expiration dates, with the capsule body marked with 'W' and 'Effexor XR' and dosage strength '37.5'.*
FDA Label Image

63187-223-30 (Venlafaxine 08)

63187-223-30 (Venlafaxine 08)
Venlafaxine Hydrochloride 37.5 mg extended-release capsules, bottle containing 30 capsules, labeled for prescription use only by Proficient Rx LP. The label includes storage instructions to keep between 20-25°C and a QR code, with the product ID RV022430 visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.